BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34744339)

  • 1. Clinico-Hematological Profile and Copy Number Abnormalities in a Cohort of
    Patra N; Singh M; Sharma P; Trehan A; Naseem S; Bansal D; Bhatia P
    Indian J Hematol Blood Transfus; 2021 Oct; 37(4):555-562. PubMed ID: 34744339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: The First Report of
    Wang HP; He JJ; Zhu QY; Wang L; Li JH; Huang JS; Xie WZ; Zhu HH; Jin J
    Front Oncol; 2021; 11():706798. PubMed ID: 34307175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
    Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
    Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia.
    Chen X; Wang F; Zhang Y; Wang M; Tian W; Teng W; Ma X; Guo L; Fang J; Zhang Y; Zhu P; Liu H
    Leuk Res; 2018 Sep; 72():99-104. PubMed ID: 30125757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and
    Chen Y; Zhang L; Huang J; Hong X; Zhao J; Wang Z; Zhang K
    Exp Ther Med; 2017 Nov; 14(5):3979-3984. PubMed ID: 29067094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic
    Stukaite-Ruibiene E; Norvilas R; Dirse V; Stankeviciene S; Vaitkeviciene GE
    Pathol Oncol Res; 2022; 28():1610570. PubMed ID: 36172171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.
    De Keersmaecker K; Porcu M; Cox L; Girardi T; Vandepoel R; de Beeck JO; Gielen O; Mentens N; Bennett KL; Hantschel O
    Haematologica; 2014 Jan; 99(1):85-93. PubMed ID: 23872305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a cryptic
    Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Koon SJ; Webley MR; McGrath M; Bayerl MG; Baughn LB; Rowsey RA; Ketterling RP; Greipp PT; Hoppman NL
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.
    Simioni C; Ultimo S; Martelli AM; Zauli G; Milani D; McCubrey JA; Capitani S; Neri LM
    Oncotarget; 2016 Nov; 7(48):79842-79853. PubMed ID: 27821800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABL1 fusions in T-cell acute lymphoblastic leukemia.
    De Keersmaecker K
    Verh K Acad Geneeskd Belg; 2008; 70(4):245-55. PubMed ID: 19166098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origins of STIL-TAL1 fusion genes in children who later developed paediatric T-cell acute lymphoblastic leukaemia: An investigation of neonatal blood spots.
    Gustafsson BM; Mattsson K; Bogdanovic G; Leijonhufvud G; Honkaniemi E; Ramme K; Ford AM
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27310. PubMed ID: 29968961
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhou MH; Yang QM
    Oncol Lett; 2014 Sep; 8(3):959-962. PubMed ID: 25120641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary analysis of pediatric T-ALL: 9q34 gene fusions.
    Papenhausen P; Kelly CA; Zhang Z; Tepperberg J; Burnside RD; Schwartz S
    Cancer Genet; 2019 Feb; 231-232():1-13. PubMed ID: 30803551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cryptic NUP214-ABL1 Fusion in B-cell Precursor Acute Lymphoblastic Leukemia.
    Tsujimoto SI; Nakano Y; Osumi T; Okada K; Ouchi-Uchiyama M; Kataoka K; Fujii Y; Ohki K; Seki M; Tamagawa N; Takita J; Ogawa S; Kiyokawa N; Hara J; Kato M
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):e397-e399. PubMed ID: 29219890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.
    Graux C; Cools J; Melotte C; Quentmeier H; Ferrando A; Levine R; Vermeesch JR; Stul M; Dutta B; Boeckx N; Bosly A; Heimann P; Uyttebroeck A; Mentens N; Somers R; MacLeod RA; Drexler HG; Look AT; Gilliland DG; Michaux L; Vandenberghe P; Wlodarska I; Marynen P; Hagemeijer A
    Nat Genet; 2004 Oct; 36(10):1084-9. PubMed ID: 15361874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NUP214-ABL1 in adult T-ALL: the GMALL study group experience.
    Burmeister T; Gökbuget N; Reinhardt R; Rieder H; Hoelzer D; Schwartz S
    Blood; 2006 Nov; 108(10):3556-9. PubMed ID: 16873673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
    Furness CL; Mansur MB; Weston VJ; Ermini L; van Delft FW; Jenkinson S; Gale R; Harrison CJ; Pombo-de-Oliveira MS; Sanchez-Martin M; Ferrando AA; Kearns P; Titley I; Ford AM; Potter NE; Greaves M
    Leukemia; 2018 Sep; 32(9):1984-1993. PubMed ID: 29556024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.
    Graux C; Stevens-Kroef M; Lafage M; Dastugue N; Harrison CJ; Mugneret F; Bahloula K; Struski S; Grégoire MJ; Nadal N; Lippert E; Taviaux S; Simons A; Kuiper RP; Moorman AV; Barber K; Bosly A; Michaux L; Vandenberghe P; Lahortiga I; De Keersmaecker K; Wlodarska I; Cools J; Hagemeijer A; Poirel HA; ;
    Leukemia; 2009 Jan; 23(1):125-33. PubMed ID: 18923437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe Amplification.
    Thakral D; Kaur G; Gupta R; Benard-Slagter A; Savola S; Kumar I; Anand R; Rani L; Verma P; Joshi S; Kumar L; Sharma A; Bakhshi S; Seth R; Singh V
    Front Oncol; 2019; 9():871. PubMed ID: 31572674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.